RT Journal Article
SR Electronic
T1 COVID-19 prediction in South Africa: Understanding the unascertained cases -- the hidden part of the epidemiological iceberg
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.10.20247361
DO 10.1101/2020.12.10.20247361
A1 Gu, Xuelin
A1 Mukherjee, Bhramar
A1 Das, Sonali
A1 Datta, Jyotishka
YR 2020
UL http://medrxiv.org/content/early/2020/12/11/2020.12.10.20247361.abstract
AB Background Understanding the impact of non-pharmaceutical interventions remains a critical epidemiological problem in South Africa that reported the largest number of confirmed COVID-19 cases and deaths from the African continent.Methods In this study, we applied two existing epidemiological models, an extension of the Susceptible-Infected-Removed model (eSIR) and SAPHIRE, to fit the daily ascertained infected (and removed) cases from March 15 to July 31 in South Africa. To combine the desirable features from the two models, we further extended the eSIR model to an eSEIRD model.Results Using the eSEIRD model, the COVID-19 transmission dynamics in South Africa was characterized by the estimated basic reproduction number (R0) at 2.10 (95%CI: [2.09,2.10]). The decrease of effective reproduction number with time implied the effectiveness of interventions. The low estimated ascertained rate was found to be 2.17% (95%CI: [2.15%, 2.19%]) in the eSEIRD model. The overall infection fatality ratio (IFR) was estimated as 0.04% (95%CI: [0.02%, 0.06%]) while the reported case fatality ratio was 4.40% (95% CI: [<0.01%, 11.81%]). As of December 31, 2020, the cumulative number of ascertained cases and total infected would reach roughly 801 thousand and 36.9 million according to the long-term forecasting.Conclusions The dynamics based on our models suggested a decline of COVID-19 infection and that the severeness of the epidemic might be largely mitigated through strict interventions. Besides providing insights on the COVID-19 dynamics in South Africa, we develop powerful forecasting tools that allow incorporating ascertained rate and IFR estimation and inquiring into the effect of intervention measures on COVID-19 spread.Key MessagesThis study delineated the COVID-19 dynamics in South Africa from March 15 to July 31 and confirmed the effectiveness of the main non-pharmaceutical intervention— lockdown, and mandatory wearing of face-mask in public places using epidemiological models;COVID-19 spread in South Africa was found to be associated with both low ascertained rate and low infection fatality ratio;According to the long-term forecast, by December 31, 2020, the cumulative number of ascertained cases and total infected would reach roughly 801 thousand and 36.9 million respectively.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from the National Science Foundation [grant numbers DMS- 1712933 (to B.M.) and DMS-2015460 (to J.D.)] and from National Institute of Health [grant number 1 R01 HG008773-01 (to B.M.)]. The first and second author (X.G. and B.M.) would also like to thank the Center for Precision Health Data Sciences at the University of Michigan School of Public Health, The University of Michigan Rogel Cancer Center and the Michigan Institute of Data Science for internal funding that supported this research. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB was needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data of this study are openly available in the COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University at https://github.com/CSSEGISandData/COVID-19. https://github.com/CSSEGISandData/COVID-19